According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK)-cell therapy targeting CD19 resulted ...
Feb 5, 2020
0
27
Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" ...
Feb 3, 2020
0
1
Some cancer cells refuse to die, even in the face of powerful cellular immunotherapies like CAR T cell therapy, and new research from the Abramson Cancer Center of the University of Pennsylvania is shedding light on why. ...
Jan 30, 2020
0
8
Why do BMW and Audi owners often seem to drive like idiots? Is it the car that makes them behave aggressively behind the wheel, or are specific types of people drawn to such cars as well being more likely to break traffic ...
Jan 29, 2020
0
5
Hundreds of Americans and Japanese escaped the quarantined Chinese city at the centre of a coronavirus epidemic aboard charter flights on Wednesday, as the death toll soared to 132 and confirmed infections neared 6,000.
Jan 29, 2020
0
2
Researchers have discovered ways to boost CAR T-cell therapy. According to a study published in the Blood journal, drug profiling and the CRISPR-Cas9 gene editing method have opened new avenues in the development of CAR T-cell ...
Jan 21, 2020
0
3
More than 2.5 million people in the United States alone experience a traumatic brain injury, or TBI, each year. Some of these people are plagued by a seemingly unrelated cascade of health issues for years after their head ...
Jan 21, 2020
0
25
For the first month and a half after receiving a modified toy car designed for children with disabilities, the kids and their families seemed motivated to use driving as a means of exploration and socialization.
Jan 10, 2020
0
5
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric ...
Dec 9, 2019
0
5
A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant to or has come back after multiple other therapies, including CAR T therapy, into remission. A global, multi-center ...
Dec 7, 2019
0
4
